(Total Views: 720)
Posted On: 03/22/2022 2:17:28 AM
Post# of 151638
Re: I_luv_cydy #120495
This is what happened on January 13th.
CytoDyn Cancels Webcast and Live Q/A Scheduled for Today
Press Release | 01/13/2022
CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced it has canceled its webcast scheduled for today, Thursday, January 13, 2022 and will provide an update at a future date.
CytoDyn Cancels Webcast and Live Q/A Scheduled for Today
Press Release | 01/13/2022
CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced it has canceled its webcast scheduled for today, Thursday, January 13, 2022 and will provide an update at a future date.
(0)
(0)Scroll down for more posts ▼
